These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2852215

  • 21. Corticotropin-releasing hormone (CRH) is decreased in the basal ganglia in Huntington's disease.
    De Souza EB, Whitehouse PJ, Folstein SE, Price DL, Vale WW.
    Brain Res; 1987 Dec 29; 437(2):355-9. PubMed ID: 2893655
    [Abstract] [Full Text] [Related]

  • 22. DBI (diazepam binding inhibitor): the precursor of a family of endogenous modulators of GABAA receptor function. History, perspectives, and clinical implications.
    Barbaccia ML, Berkovich A, Guarneri P, Slobodyansky E.
    Neurochem Res; 1990 Feb 29; 15(2):161-8. PubMed ID: 2159121
    [Abstract] [Full Text] [Related]

  • 23. Structure-activity relationship of peptide fragments derived from DBI (diazepam binding inhibitor), a putative endogenous ligand of benzodiazepine recognition sites.
    Guidotti A, Santi MR, Berkovich A, Ferrarese C, Costa E.
    Clin Neuropharmacol; 1986 Feb 29; 9 Suppl 4():217-9. PubMed ID: 3032426
    [No Abstract] [Full Text] [Related]

  • 24. Co-localization and co-release of GABA and putative allosteric modulators of GABA receptor.
    Ferrarese C, Alho H, Guidotti A, Costa E.
    Neuropharmacology; 1987 Jul 29; 26(7B):1011-8. PubMed ID: 2821427
    [Abstract] [Full Text] [Related]

  • 25. Peripheral-type benzodiazepine receptors and diazepam binding inhibitor-like immunoreactivity distribution in human peripheral blood mononuclear cells.
    Rocca P, Bellone G, Benna P, Bergamasco B, Ravizza L, Ferrero P.
    Immunopharmacology; 1993 Jul 29; 25(2):163-78. PubMed ID: 8388870
    [Abstract] [Full Text] [Related]

  • 26. Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors.
    Papadopoulos V, Berkovich A, Krueger KE, Costa E, Guidotti A.
    Endocrinology; 1991 Sep 29; 129(3):1481-8. PubMed ID: 1651852
    [Abstract] [Full Text] [Related]

  • 27. NMDA receptor losses in putamen from patients with Huntington's disease.
    Young AB, Greenamyre JT, Hollingsworth Z, Albin R, D'Amato C, Shoulson I, Penney JB.
    Science; 1988 Aug 19; 241(4868):981-3. PubMed ID: 2841762
    [Abstract] [Full Text] [Related]

  • 28. Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's disease.
    Ellison DW, Beal MF, Mazurek MF, Malloy JR, Bird ED, Martin JB.
    Brain; 1987 Dec 19; 110 ( Pt 6)():1657-73. PubMed ID: 2892568
    [Abstract] [Full Text] [Related]

  • 29. Benzodiazepine receptors and diazepam-binding inhibitor in human cerebral tumors.
    Ferrarese C, Appollonio I, Frigo M, Gaini SM, Piolti R, Frattola L.
    Ann Neurol; 1989 Oct 19; 26(4):564-8. PubMed ID: 2554790
    [Abstract] [Full Text] [Related]

  • 30. Increased brain content of the endogenous benzodiazepine receptor ligand, octadecaneuropeptide (ODN), following portacaval anastomosis in the rat.
    Butterworth RF, Tonon MC, Désy L, Giguère JF, Vaudry H, Pelletier G.
    Peptides; 1991 Oct 19; 12(1):119-25. PubMed ID: 1646996
    [Abstract] [Full Text] [Related]

  • 31. Cerebrospinal fluid levels of diazepam-binding inhibitor in neurodegenerative disorders with dementia.
    Ferrarese C, Appollonio I, Frigo M, Meregalli S, Piolti R, Tamma F, Frattola L.
    Neurology; 1990 Apr 19; 40(4):632-5. PubMed ID: 2138718
    [Abstract] [Full Text] [Related]

  • 32. Altered behavioral responses to gamma-aminobutyric acid pharmacological agents in a mouse model of Huntington's disease.
    Hsu YT, Chang YG, Chang CP, Siew JJ, Chen HM, Tsai CH, Chern Y.
    Mov Disord; 2017 Nov 19; 32(11):1600-1609. PubMed ID: 28782830
    [Abstract] [Full Text] [Related]

  • 33. Huntington's disease: changes in striatal proteins reflect astrocytic gliosis.
    Selkoe DJ, Salazar FJ, Abraham C, Kosik KS.
    Brain Res; 1982 Aug 05; 245(1):117-25. PubMed ID: 6214299
    [Abstract] [Full Text] [Related]

  • 34. A natural processing product of rat diazepam binding inhibitor, triakontatetraneuropeptide (diazepam binding inhibitor 17-50) contains an alpha-helix, which allows discrimination between benzodiazepine binding site subtypes.
    Berkovich A, McPhie P, Campagnone M, Guidotti A, Hensley P.
    Mol Pharmacol; 1990 Feb 05; 37(2):164-72. PubMed ID: 2154668
    [Abstract] [Full Text] [Related]

  • 35. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M, Desmond TJ, Albin RL, Frey KA.
    Synapse; 2001 Sep 15; 41(4):329-36. PubMed ID: 11494403
    [Abstract] [Full Text] [Related]

  • 36. GABA(A) receptor subunit and gephyrin protein changes differ in the globus pallidus in Huntington's diseased brain.
    Thompson-Vest NM, Waldvogel HJ, Rees MI, Faull RL.
    Brain Res; 2003 Dec 24; 994(2):265-70. PubMed ID: 14642653
    [Abstract] [Full Text] [Related]

  • 37. Decrease of mGluR5 receptor density goes parallel with changes in enkephalin and substance P immunoreactivity in Huntington's disease: a preliminary investigation in the postmortem human brain.
    Gulyás B, Sovago J, Gomez-Mancilla B, Jia Z, Szigeti C, Gulya K, Schumacher M, Maguire RP, Gasparini F, Halldin C.
    Brain Struct Funct; 2015 Sep 24; 220(5):3043-51. PubMed ID: 24969128
    [Abstract] [Full Text] [Related]

  • 38. Benzodiazepine receptors: the effect of GABA on their characteristics in human brain and their alteration in Huntington's disease.
    Reisine TD, Overstreet D, Gale K, Rossor M, Iversen L, Yamamura HI.
    Brain Res; 1980 Oct 13; 199(1):79-88. PubMed ID: 6105905
    [Abstract] [Full Text] [Related]

  • 39. Subregion-Specific Impacts of Genetic Loss of Diazepam Binding Inhibitor on Synaptic Inhibition in the Murine Hippocampus.
    Courtney CD, Christian CA.
    Neuroscience; 2018 Sep 15; 388():128-138. PubMed ID: 30031126
    [Abstract] [Full Text] [Related]

  • 40. Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington's disease.
    Emson PC, Arregui A, Clement-Jones V, Sandberg BE, Rossor M.
    Brain Res; 1980 Oct 13; 199(1):147-60. PubMed ID: 6157454
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.